Contribution of growth hormone and IGF-I to early diabetic nephropathy in type 1 diabetes

被引:80
|
作者
Cummings, EA [1 ]
Sochett, EB [1 ]
Dekker, MG [1 ]
Lawson, ML [1 ]
Daneman, D [1 ]
机构
[1] Univ Toronto, Hosp Sick Children, Dept Pediat, Div Endocrinol, Toronto, ON M5G 1X8, Canada
关键词
D O I
10.2337/diabetes.47.8.1341
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
In children and adolescents with type 1 diabetes, we have reported an association between duration of puberty and the prevalence of nephromegaly and microalbuminuria (MA), which are early markers of diabetic nephropathy. Growth hormone (GH), IGF-I, testosterone, and prorenin are potential mediators of this effect. This study examined the relationship of these hormonal factors to kidney volume (KV) and MA in 155 subjects (78 males, age 13.2 +/- 3.5 years [mean +/- SD]) with similar diabetes duration (6.83 +/- 1.6 years) but varying pubertal experience (0-10 years). KV (by ultrasound), plasma IGF-I, testosterone, prorenin, and NaLi countertransport, and urinary albumin, urinary GH, and urinary IGF-I from three 24-h collections were measured. Multiple regression analysis showed that BSA (P +/- 0.0001) and urinary IGF-I (P = 0.001) were significantly associated with KV. MA subjects (albumin excretion rate 15-200 mu g/min) had higher urinary IGF-I (P = 0.005) and urinary GH (P = 0.05) compared with normoalbuminuric subjects. Only 9% of the variance in urinary IGF-I could be attributed to plasma IGF-I (r = 0.30, P < 0.0001). Testosterone and prorenin were not associated with MA, but they were associated with KV in univariate analyses. The strong association of urinary IGF-I with KV, a marker for glomerular hypertrophy, and of both urinary IGF-I and urinary GH with RIA suggests a role for these growth factors in the development of human diabetic nephropathy. Together, these data support animal studies that have shown that renal GH and IGF-I may contribute significantly to the pathogenesis of early diabetic nephropathy.
引用
收藏
页码:1341 / 1346
页数:6
相关论文
共 50 条
  • [1] Association of IGF-I gene polymorphism with diabetic nephropathy in Egyptians with type 2 diabetes
    Mohamed A. M. Hegazi
    Amal Seleem
    Eman H. EL-Adawy
    Mahmoud E. A. Elhussini
    The Egyptian Journal of Internal Medicine, 2018, 30 (4) : 191 - 196
  • [2] Growth hormone, IGF-I and diabetic angiopathy revisited
    Moller, N
    Orskov, H
    CLINICAL ENDOCRINOLOGY, 2000, 52 (01) : 11 - 12
  • [3] Interaction between IGF-I, insulin and growth hormone in type II diabetes
    Clemmons, DR
    JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM, 1997, 10 : 97 - 104
  • [4] Growth hormone and IGF-I in diabetic children with and without microalbuminuria
    Verrotti, A
    Cieri, F
    Petitti, MT
    Morgese, G
    Chiarelli, F
    DIABETES NUTRITION & METABOLISM, 1999, 12 (04) : 271 - 276
  • [5] Growth hormone-binding proteins, IGF-I and IGF-binding proteins in children and adolescents with type 1 diabetes mellitus
    Radetti, G
    Paganini, C
    Antoniazzi, F
    Pasquino, B
    Valentini, R
    Gentili, L
    Tato, L
    HORMONE RESEARCH, 1997, 47 (03) : 110 - 115
  • [6] INSULIN, IGF-I AND GROWTH IN DIABETIC RATS
    ROBINSON, ICAF
    CLARK, RG
    CARLSSON, LMS
    NATURE, 1987, 326 (6113) : 549 - 549
  • [7] IGF-I treatment of growth hormone insensitivity
    Rosenfeld, RG
    MOLECULAR MECHANISMS TO REGULATE THE ACTIVITIES OF INSULIN-LIKE GROWTH FACTORS, 1998, 1151 : 359 - 364
  • [8] Verapamil Prevents Decline of IGF-I in Subjects With Type 1 Diabetes and Promotes β-Cell IGF-I Signaling
    Xu, Guanlan
    Chen, Junqin
    Lu, Brian
    Sethupathy, Praveen
    Qian, Wei-Jun
    Shalev, Anath
    DIABETES, 2023, 72 (10) : 1460 - 1469
  • [9] IGF-I and IGFBP-1 in Indian diabetic populations: Type 1, type 2 and malnutritional diabetes.
    Brismar, K
    Kanungo, A
    Samal, KC
    Tripathy, BB
    Sanjeevi, CB
    DIABETOLOGIA, 2000, 43 : A177 - A177
  • [10] Regulation of insulin-like growth factor I (IGF-I) and receptors for IGF-I and growth hormone in the heart
    Isgaard, J
    Friberg, P
    ENDOCRINOLOGY AND METABOLISM, 1997, 4 : 15 - 19